BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17536082)

  • 1. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of HLA class I expression by Reed-Sternberg cells.
    Poppema S; Visser L
    Am J Pathol; 1994 Jul; 145(1):37-41. PubMed ID: 7518195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
    Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
    J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
    Sup SJ; Alemañy CA; Pohlman B; Elson P; Malhi S; Thakkar S; Steinle R; Hsi ED
    J Clin Oncol; 2005 Jun; 23(16):3773-9. PubMed ID: 15809450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
    Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
    J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
    Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
    Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
    Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.
    Tzankov A; Krugmann J; Fend F; Fischhofer M; Greil R; Dirnhofer S
    Clin Cancer Res; 2003 Apr; 9(4):1381-6. PubMed ID: 12684408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method.
    Vasef MA; Alsabeh R; Medeiros LJ; Weiss LM
    Am J Clin Pathol; 1997 Jul; 108(1):54-9. PubMed ID: 9208978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.